nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—bone cancer—peripheral nervous system neoplasm	0.211	0.557	CtDrD
Cisplatin—germ cell cancer—peripheral nervous system neoplasm	0.168	0.442	CtDrD
Cisplatin—BCHE—peripheral nervous system neoplasm	0.139	0.719	CbGaD
Cisplatin—ABCB1—peripheral nervous system neoplasm	0.0543	0.282	CbGaD
Cisplatin—CYP4A11—Tretinoin—peripheral nervous system neoplasm	0.0503	0.161	CbGbCtD
Cisplatin—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.0375	0.12	CbGbCtD
Cisplatin—GSTT1—Etoposide—peripheral nervous system neoplasm	0.0368	0.118	CbGbCtD
Cisplatin—GSTP1—Etoposide—peripheral nervous system neoplasm	0.023	0.0738	CbGbCtD
Cisplatin—ABCC6—Etoposide—peripheral nervous system neoplasm	0.0212	0.0678	CbGbCtD
Cisplatin—NQO1—Doxorubicin—peripheral nervous system neoplasm	0.0173	0.0553	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.0144	0.0463	CbGbCtD
Cisplatin—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0111	0.0356	CbGbCtD
Cisplatin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0107	0.0342	CbGbCtD
Cisplatin—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0102	0.0326	CbGbCtD
Cisplatin—XDH—Doxorubicin—peripheral nervous system neoplasm	0.00902	0.0289	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0074	0.0237	CbGbCtD
Cisplatin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.00698	0.0224	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.00693	0.0222	CbGbCtD
Cisplatin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00504	0.0162	CbGbCtD
Cisplatin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00462	0.0148	CbGbCtD
Cisplatin—PTGS2—Etoposide—peripheral nervous system neoplasm	0.00457	0.0146	CbGbCtD
Cisplatin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00456	0.0146	CbGbCtD
Cisplatin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00418	0.0134	CbGbCtD
Cisplatin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00385	0.0123	CbGbCtD
Cisplatin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00385	0.0123	CbGbCtD
Cisplatin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00369	0.0118	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00315	0.0101	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00285	0.00913	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00267	0.00856	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.002	0.00642	CbGbCtD
Cisplatin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00164	0.00527	CbGbCtD
Cisplatin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00151	0.00483	CbGbCtD
Cisplatin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00329	CbGbCtD
Cisplatin—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00103	1	CbGdCrCtD
Cisplatin—NQO1—ganglion—peripheral nervous system neoplasm	0.000283	0.0673	CbGeAlD
Cisplatin—SLC31A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000271	0.0643	CbGeAlD
Cisplatin—SLC31A2—parotid gland—peripheral nervous system neoplasm	0.000255	0.0606	CbGeAlD
Cisplatin—ATP7A—trigeminal ganglion—peripheral nervous system neoplasm	0.000238	0.0566	CbGeAlD
Cisplatin—ATP7A—parotid gland—peripheral nervous system neoplasm	0.000225	0.0534	CbGeAlD
Cisplatin—SOD1—trigeminal ganglion—peripheral nervous system neoplasm	0.000209	0.0495	CbGeAlD
Cisplatin—SLC31A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000203	0.0483	CbGeAlD
Cisplatin—SOD1—parotid gland—peripheral nervous system neoplasm	0.000197	0.0467	CbGeAlD
Cisplatin—SLC31A1—parotid gland—peripheral nervous system neoplasm	0.000192	0.0455	CbGeAlD
Cisplatin—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000157	0.0374	CbGeAlD
Cisplatin—ABCC5—trigeminal ganglion—peripheral nervous system neoplasm	0.000149	0.0353	CbGeAlD
Cisplatin—MT1A—cerebellum—peripheral nervous system neoplasm	0.000144	0.0342	CbGeAlD
Cisplatin—NQO1—trigeminal ganglion—peripheral nervous system neoplasm	0.000139	0.033	CbGeAlD
Cisplatin—NQO1—parotid gland—peripheral nervous system neoplasm	0.000131	0.0312	CbGeAlD
Cisplatin—ATP7B—cerebellum—peripheral nervous system neoplasm	0.000129	0.0307	CbGeAlD
Cisplatin—GSTP1—trigeminal ganglion—peripheral nervous system neoplasm	0.000124	0.0295	CbGeAlD
Cisplatin—SLC31A2—cerebellum—peripheral nervous system neoplasm	0.000118	0.028	CbGeAlD
Cisplatin—GSTP1—parotid gland—peripheral nervous system neoplasm	0.000117	0.0278	CbGeAlD
Cisplatin—SOD1—cerebellum—peripheral nervous system neoplasm	9.1e-05	0.0216	CbGeAlD
Cisplatin—SLC31A1—cerebellum—peripheral nervous system neoplasm	8.87e-05	0.0211	CbGeAlD
Cisplatin—GSTM1—cerebellum—peripheral nervous system neoplasm	8.66e-05	0.0206	CbGeAlD
Cisplatin—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	7.53e-05	0.0179	CbGeAlD
Cisplatin—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	7.28e-05	0.0173	CbGeAlD
Cisplatin—ABCG2—parotid gland—peripheral nervous system neoplasm	6.86e-05	0.0163	CbGeAlD
Cisplatin—BCHE—brainstem—peripheral nervous system neoplasm	6.66e-05	0.0158	CbGeAlD
Cisplatin—ABCC5—cerebellum—peripheral nervous system neoplasm	6.49e-05	0.0154	CbGeAlD
Cisplatin—NQO1—cerebellum—peripheral nervous system neoplasm	6.07e-05	0.0144	CbGeAlD
Cisplatin—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	5.8e-05	0.0138	CbGeAlD
Cisplatin—GSTP1—cerebellum—peripheral nervous system neoplasm	5.42e-05	0.0129	CbGeAlD
Cisplatin—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	5.03e-05	0.000615	CcSEcCtD
Cisplatin—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000614	CcSEcCtD
Cisplatin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	5.02e-05	0.000613	CcSEcCtD
Cisplatin—Oedema—Vincristine—peripheral nervous system neoplasm	5.02e-05	0.000613	CcSEcCtD
Cisplatin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	5e-05	0.000611	CcSEcCtD
Cisplatin—Infection—Vincristine—peripheral nervous system neoplasm	4.98e-05	0.000609	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000609	CcSEcCtD
Cisplatin—Asthenia—Topotecan—peripheral nervous system neoplasm	4.97e-05	0.000607	CcSEcCtD
Cisplatin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	4.96e-05	0.000607	CcSEcCtD
Cisplatin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	4.93e-05	0.000603	CcSEcCtD
Cisplatin—Asthenia—Tretinoin—peripheral nervous system neoplasm	4.93e-05	0.000603	CcSEcCtD
Cisplatin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	4.92e-05	0.000601	CcSEcCtD
Cisplatin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	4.91e-05	0.000601	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	4.88e-05	0.000597	CcSEcCtD
Cisplatin—Asthenia—Melphalan—peripheral nervous system neoplasm	4.87e-05	0.000595	CcSEcCtD
Cisplatin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	4.87e-05	0.000595	CcSEcCtD
Cisplatin—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	4.85e-05	0.000593	CcSEcCtD
Cisplatin—Pain—Dactinomycin—peripheral nervous system neoplasm	4.8e-05	0.000587	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000585	CcSEcCtD
Cisplatin—Muscle spasms—Etoposide—peripheral nervous system neoplasm	4.79e-05	0.000585	CcSEcCtD
Cisplatin—Anorexia—Vincristine—peripheral nervous system neoplasm	4.78e-05	0.000585	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	4.74e-05	0.00058	CcSEcCtD
Cisplatin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	4.74e-05	0.000579	CcSEcCtD
Cisplatin—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000578	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000578	CcSEcCtD
Cisplatin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	4.7e-05	0.000575	CcSEcCtD
Cisplatin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	4.7e-05	0.000575	CcSEcCtD
Cisplatin—Hypotension—Vincristine—peripheral nervous system neoplasm	4.69e-05	0.000573	CcSEcCtD
Cisplatin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	4.68e-05	0.000572	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000569	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000568	CcSEcCtD
Cisplatin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	4.64e-05	0.000567	CcSEcCtD
Cisplatin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	4.64e-05	0.000567	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000567	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	4.63e-05	0.000566	CcSEcCtD
Cisplatin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	4.62e-05	0.000565	CcSEcCtD
Cisplatin—Anaemia—Etoposide—peripheral nervous system neoplasm	4.6e-05	0.000563	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000559	CcSEcCtD
Cisplatin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	4.53e-05	0.000553	CcSEcCtD
Cisplatin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	4.51e-05	0.000551	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	4.5e-05	0.00055	CcSEcCtD
Cisplatin—Malaise—Etoposide—peripheral nervous system neoplasm	4.49e-05	0.000549	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000547	CcSEcCtD
Cisplatin—Leukopenia—Etoposide—peripheral nervous system neoplasm	4.46e-05	0.000545	CcSEcCtD
Cisplatin—Pain—Alitretinoin—peripheral nervous system neoplasm	4.45e-05	0.000544	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	4.44e-05	0.000543	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000542	CcSEcCtD
Cisplatin—Vomiting—Topotecan—peripheral nervous system neoplasm	4.4e-05	0.000538	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000535	CcSEcCtD
Cisplatin—Vomiting—Tretinoin—peripheral nervous system neoplasm	4.37e-05	0.000534	CcSEcCtD
Cisplatin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	4.37e-05	0.000534	CcSEcCtD
Cisplatin—Rash—Topotecan—peripheral nervous system neoplasm	4.37e-05	0.000534	CcSEcCtD
Cisplatin—Dermatitis—Topotecan—peripheral nervous system neoplasm	4.36e-05	0.000533	CcSEcCtD
Cisplatin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	4.36e-05	0.000533	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000531	CcSEcCtD
Cisplatin—Rash—Tretinoin—peripheral nervous system neoplasm	4.33e-05	0.00053	CcSEcCtD
Cisplatin—Rash—Isotretinoin—peripheral nervous system neoplasm	4.33e-05	0.00053	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	4.33e-05	0.00053	CcSEcCtD
Cisplatin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	4.33e-05	0.000529	CcSEcCtD
Cisplatin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	4.33e-05	0.000529	CcSEcCtD
Cisplatin—Convulsion—Etoposide—peripheral nervous system neoplasm	4.31e-05	0.000527	CcSEcCtD
Cisplatin—Vomiting—Melphalan—peripheral nervous system neoplasm	4.31e-05	0.000527	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000527	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000526	CcSEcCtD
Cisplatin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	4.29e-05	0.000525	CcSEcCtD
Cisplatin—Pain—Vincristine—peripheral nervous system neoplasm	4.29e-05	0.000524	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000524	CcSEcCtD
Cisplatin—Rash—Melphalan—peripheral nervous system neoplasm	4.28e-05	0.000523	CcSEcCtD
Cisplatin—Dermatitis—Melphalan—peripheral nervous system neoplasm	4.27e-05	0.000522	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000518	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	4.22e-05	0.000516	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	4.21e-05	0.000515	CcSEcCtD
Cisplatin—Discomfort—Etoposide—peripheral nervous system neoplasm	4.19e-05	0.000512	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000512	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00051	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000507	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000506	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	4.14e-05	0.000506	CcSEcCtD
Cisplatin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	4.12e-05	0.000503	CcSEcCtD
Cisplatin—Nausea—Topotecan—peripheral nervous system neoplasm	4.11e-05	0.000503	CcSEcCtD
Cisplatin—Nausea—Isotretinoin—peripheral nervous system neoplasm	4.08e-05	0.000499	CcSEcCtD
Cisplatin—Nausea—Tretinoin—peripheral nervous system neoplasm	4.08e-05	0.000499	CcSEcCtD
Cisplatin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	4.06e-05	0.000497	CcSEcCtD
Cisplatin—Infection—Etoposide—peripheral nervous system neoplasm	4.04e-05	0.000494	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	4.03e-05	0.000493	CcSEcCtD
Cisplatin—Nausea—Melphalan—peripheral nervous system neoplasm	4.03e-05	0.000492	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000491	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000488	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	3.98e-05	0.000486	CcSEcCtD
Cisplatin—Tachycardia—Etoposide—peripheral nervous system neoplasm	3.97e-05	0.000485	CcSEcCtD
Cisplatin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	3.97e-05	0.000485	CcSEcCtD
Cisplatin—Skin disorder—Etoposide—peripheral nervous system neoplasm	3.95e-05	0.000483	CcSEcCtD
Cisplatin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	3.93e-05	0.00048	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.00048	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000479	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000477	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000474	CcSEcCtD
Cisplatin—Anorexia—Etoposide—peripheral nervous system neoplasm	3.87e-05	0.000474	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000472	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	3.84e-05	0.00047	CcSEcCtD
Cisplatin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	3.84e-05	0.000469	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000469	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000465	CcSEcCtD
Cisplatin—Hypotension—Etoposide—peripheral nervous system neoplasm	3.8e-05	0.000464	CcSEcCtD
Cisplatin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	3.74e-05	0.000457	CcSEcCtD
Cisplatin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	3.7e-05	0.000452	CcSEcCtD
Cisplatin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	3.65e-05	0.000446	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000444	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	3.62e-05	0.000443	CcSEcCtD
Cisplatin—Asthenia—Vincristine—peripheral nervous system neoplasm	3.6e-05	0.00044	CcSEcCtD
Cisplatin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	3.59e-05	0.00852	CbGeAlD
Cisplatin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	3.57e-05	0.000436	CcSEcCtD
Cisplatin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	3.56e-05	0.000436	CcSEcCtD
Cisplatin—Rash—Dactinomycin—peripheral nervous system neoplasm	3.54e-05	0.000433	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	3.53e-05	0.000432	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.00043	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.000429	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	3.51e-05	0.000429	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000428	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000426	CcSEcCtD
Cisplatin—Pain—Etoposide—peripheral nervous system neoplasm	3.48e-05	0.000425	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000424	CcSEcCtD
Cisplatin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	3.43e-05	0.00042	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000413	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	3.35e-05	0.000409	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—peripheral nervous system neoplasm	3.34e-05	0.000408	CcSEcCtD
Cisplatin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	3.31e-05	0.000405	CcSEcCtD
Cisplatin—BCHE—cerebellum—peripheral nervous system neoplasm	3.28e-05	0.0078	CbGeAlD
Cisplatin—Rash—Alitretinoin—peripheral nervous system neoplasm	3.28e-05	0.000401	CcSEcCtD
Cisplatin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	3.28e-05	0.000401	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000399	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000397	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000396	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000394	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	3.21e-05	0.000393	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000393	CcSEcCtD
Cisplatin—Vomiting—Vincristine—peripheral nervous system neoplasm	3.19e-05	0.00039	CcSEcCtD
Cisplatin—ABCG2—cerebellum—peripheral nervous system neoplasm	3.17e-05	0.00754	CbGeAlD
Cisplatin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000387	CcSEcCtD
Cisplatin—Rash—Vincristine—peripheral nervous system neoplasm	3.16e-05	0.000387	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—peripheral nervous system neoplasm	3.16e-05	0.000386	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000385	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000384	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000382	CcSEcCtD
Cisplatin—Nausea—Alitretinoin—peripheral nervous system neoplasm	3.09e-05	0.000378	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000378	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000369	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000366	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.99e-05	0.000366	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	2.99e-05	0.000366	CcSEcCtD
Cisplatin—Nausea—Vincristine—peripheral nervous system neoplasm	2.98e-05	0.000364	CcSEcCtD
Cisplatin—Flushing—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000364	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000364	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000358	CcSEcCtD
Cisplatin—Asthenia—Etoposide—peripheral nervous system neoplasm	2.92e-05	0.000356	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000356	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000356	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000354	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000353	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.00035	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.00035	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.83e-05	0.000346	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000341	CcSEcCtD
Cisplatin—Erythema—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000341	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.78e-05	0.00034	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000339	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000338	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000337	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000337	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000336	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	2.69e-05	0.000931	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NME1—peripheral nervous system neoplasm	2.68e-05	0.000928	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—BCHE—peripheral nervous system neoplasm	2.68e-05	0.000928	CbGpPWpGaD
Cisplatin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000328	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000328	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000327	CcSEcCtD
Cisplatin—GSTP1—Metabolism—COX2—peripheral nervous system neoplasm	2.65e-05	0.000917	CbGpPWpGaD
Cisplatin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000324	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000322	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.000321	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000317	CcSEcCtD
Cisplatin—Vomiting—Etoposide—peripheral nervous system neoplasm	2.58e-05	0.000316	CcSEcCtD
Cisplatin—NQO1—Metabolism—COX2—peripheral nervous system neoplasm	2.58e-05	0.000894	CbGpPWpGaD
Cisplatin—Erythema—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000316	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000316	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000315	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.57e-05	0.00089	CbGpPWpGaD
Cisplatin—Rash—Etoposide—peripheral nervous system neoplasm	2.56e-05	0.000313	CcSEcCtD
Cisplatin—GSTT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.56e-05	0.000886	CbGpPWpGaD
Cisplatin—Dermatitis—Etoposide—peripheral nervous system neoplasm	2.56e-05	0.000313	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000311	CcSEcCtD
Cisplatin—PTGS2—cerebellum—peripheral nervous system neoplasm	2.53e-05	0.00601	CbGeAlD
Cisplatin—GSTT1—Metabolism—TH—peripheral nervous system neoplasm	2.52e-05	0.000873	CbGpPWpGaD
Cisplatin—Malaise—Epirubicin—peripheral nervous system neoplasm	2.52e-05	0.000308	CcSEcCtD
Cisplatin—XDH—Metabolism—GNS—peripheral nervous system neoplasm	2.51e-05	0.000869	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.51e-05	0.000868	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.51e-05	0.000867	CbGpPWpGaD
Cisplatin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000305	CcSEcCtD
Cisplatin—MT2A—Immune System—HGF—peripheral nervous system neoplasm	2.49e-05	0.000861	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.49e-05	0.00086	CbGpPWpGaD
Cisplatin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000304	CcSEcCtD
Cisplatin—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.48e-05	0.000858	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	2.46e-05	0.000852	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.46e-05	0.000849	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	2.45e-05	0.000847	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000846	CbGpPWpGaD
Cisplatin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000298	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000296	CcSEcCtD
Cisplatin—Nausea—Etoposide—peripheral nervous system neoplasm	2.41e-05	0.000295	CcSEcCtD
Cisplatin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.41e-05	0.000834	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNS—peripheral nervous system neoplasm	2.41e-05	0.000833	CbGpPWpGaD
Cisplatin—XDH—Metabolism—NME1—peripheral nervous system neoplasm	2.41e-05	0.000833	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.4e-05	0.00083	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.4e-05	0.000829	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000293	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000292	CcSEcCtD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.39e-05	0.000825	CbGpPWpGaD
Cisplatin—Myalgia—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.000291	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.00029	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000289	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.36e-05	0.000815	CbGpPWpGaD
Cisplatin—Discomfort—Epirubicin—peripheral nervous system neoplasm	2.35e-05	0.000287	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	0.000285	CcSEcCtD
Cisplatin—XDH—Metabolism—COX2—peripheral nervous system neoplasm	2.32e-05	0.000802	CbGpPWpGaD
Cisplatin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000283	CcSEcCtD
Cisplatin—ABCC5—Metabolism—NME1—peripheral nervous system neoplasm	2.31e-05	0.000798	CbGpPWpGaD
Cisplatin—Oedema—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000279	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000279	CcSEcCtD
Cisplatin—Infection—Epirubicin—peripheral nervous system neoplasm	2.26e-05	0.000277	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000274	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.23e-05	0.000273	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.23e-05	0.000273	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.22e-05	0.000272	CcSEcCtD
Cisplatin—ABCC5—Metabolism—COX2—peripheral nervous system neoplasm	2.22e-05	0.000768	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.22e-05	0.000767	CbGpPWpGaD
Cisplatin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.21e-05	0.000271	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.000269	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000269	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000268	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	2.19e-05	0.000756	CbGpPWpGaD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	0.000267	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	0.000266	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.17e-05	0.000265	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.15e-05	0.000743	CbGpPWpGaD
Cisplatin—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.13e-05	0.00026	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	0.000258	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	0.000258	CcSEcCtD
Cisplatin—Infection—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	0.000256	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—GNS—peripheral nervous system neoplasm	2.09e-05	0.000722	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.000254	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000253	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.000252	CcSEcCtD
Cisplatin—GSTT1—Metabolism—GNAS—peripheral nervous system neoplasm	2.06e-05	0.000713	CbGpPWpGaD
Cisplatin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.000252	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.05e-05	0.00025	CcSEcCtD
Cisplatin—GSTM1—Metabolism—ENO2—peripheral nervous system neoplasm	2.05e-05	0.000708	CbGpPWpGaD
Cisplatin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.00025	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.04e-05	0.000706	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.04e-05	0.000249	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.03e-05	0.000248	CcSEcCtD
Cisplatin—GSTT1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.02e-05	0.000699	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.02e-05	0.000699	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PPP3R1—peripheral nervous system neoplasm	2.01e-05	0.000695	CbGpPWpGaD
Cisplatin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.01e-05	0.000246	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—NME1—peripheral nervous system neoplasm	2e-05	0.000692	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.98e-05	0.000685	CbGpPWpGaD
Cisplatin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.98e-05	0.000242	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	0.000241	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.97e-05	0.000681	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.97e-05	0.00024	CcSEcCtD
Cisplatin—Pain—Epirubicin—peripheral nervous system neoplasm	1.95e-05	0.000238	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.94e-05	0.000669	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—COX2—peripheral nervous system neoplasm	1.93e-05	0.000666	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000235	CcSEcCtD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.92e-05	0.000664	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.91e-05	0.000661	CbGpPWpGaD
Cisplatin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000231	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.88e-05	0.000651	CbGpPWpGaD
Cisplatin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.00023	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.00023	CcSEcCtD
Cisplatin—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.88e-05	0.000649	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.85e-05	0.00064	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.84e-05	0.000635	CbGpPWpGaD
Cisplatin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	0.000224	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	0.000222	CcSEcCtD
Cisplatin—MT2A—Immune System—PTPN11—peripheral nervous system neoplasm	1.82e-05	0.000628	CbGpPWpGaD
Cisplatin—Pain—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	0.00022	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.00022	CcSEcCtD
Cisplatin—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.000614	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ENO2—peripheral nervous system neoplasm	1.74e-05	0.000602	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ENO2—peripheral nervous system neoplasm	1.74e-05	0.000602	CbGpPWpGaD
Cisplatin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000212	CcSEcCtD
Cisplatin—GSTM1—Metabolism—BCHE—peripheral nervous system neoplasm	1.73e-05	0.000598	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	1.72e-05	0.000594	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	1.7e-05	0.000589	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ENO2—peripheral nervous system neoplasm	1.7e-05	0.000587	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.69e-05	0.000585	CbGpPWpGaD
Cisplatin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000205	CcSEcCtD
Cisplatin—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.68e-05	0.000579	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.67e-05	0.000578	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000578	CbGpPWpGaD
Cisplatin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000204	CcSEcCtD
Cisplatin—GSTM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-05	0.000571	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.000567	CbGpPWpGaD
Cisplatin—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.0002	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.63e-05	0.000565	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.000562	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.62e-05	0.000559	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	1.59e-05	0.00055	CbGpPWpGaD
Cisplatin—ABCB1—cerebellum—peripheral nervous system neoplasm	1.57e-05	0.00372	CbGeAlD
Cisplatin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.56e-05	0.000191	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.00019	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.52e-05	0.000527	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	1.52e-05	0.000526	CbGpPWpGaD
Cisplatin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.51e-05	0.000185	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	1.5e-05	0.000518	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.49e-05	0.000515	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	1.48e-05	0.000512	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000509	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.47e-05	0.000507	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.46e-05	0.000505	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ENO2—peripheral nervous system neoplasm	1.46e-05	0.000505	CbGpPWpGaD
Cisplatin—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.45e-05	0.000177	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	1.45e-05	0.0005	CbGpPWpGaD
Cisplatin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.44e-05	0.000176	CcSEcCtD
Cisplatin—Rash—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000176	CcSEcCtD
Cisplatin—MT2A—Immune System—ERBB2—peripheral nervous system neoplasm	1.44e-05	0.000496	CbGpPWpGaD
Cisplatin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000175	CcSEcCtD
Cisplatin—NQO1—Metabolism—BCHE—peripheral nervous system neoplasm	1.43e-05	0.000496	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.41e-05	0.000488	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000486	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000485	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.4e-05	0.000482	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.000478	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000473	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	1.36e-05	0.000469	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.36e-05	0.000469	CbGpPWpGaD
Cisplatin—Nausea—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000165	CcSEcCtD
Cisplatin—NQO1—Metabolism—TH—peripheral nervous system neoplasm	1.35e-05	0.000466	CbGpPWpGaD
Cisplatin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000164	CcSEcCtD
Cisplatin—SOD1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.33e-05	0.000461	CbGpPWpGaD
Cisplatin—Rash—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000162	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000162	CcSEcCtD
Cisplatin—GSTM1—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.000459	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.3e-05	0.000451	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.000451	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	1.3e-05	0.00045	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.29e-05	0.000447	CbGpPWpGaD
Cisplatin—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	1.29e-05	0.000445	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.000441	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.27e-05	0.000438	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ENO2—peripheral nervous system neoplasm	1.26e-05	0.000437	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.26e-05	0.000437	CbGpPWpGaD
Cisplatin—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.000153	CcSEcCtD
Cisplatin—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000433	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.24e-05	0.000429	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—BCHE—peripheral nervous system neoplasm	1.23e-05	0.000426	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.23e-05	0.000424	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.22e-05	0.000423	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	1.21e-05	0.000419	CbGpPWpGaD
Cisplatin—XDH—Metabolism—TH—peripheral nervous system neoplasm	1.21e-05	0.000418	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000408	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000407	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.17e-05	0.000406	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	1.16e-05	0.000402	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	1.16e-05	0.000402	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—TH—peripheral nervous system neoplasm	1.16e-05	0.000401	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.16e-05	0.000401	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.13e-05	0.000391	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.00039	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	1.13e-05	0.00039	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	1.12e-05	0.000387	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GNS—peripheral nervous system neoplasm	1.11e-05	0.000385	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000383	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00038	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—peripheral nervous system neoplasm	1.09e-05	0.000378	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.000375	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.08e-05	0.000373	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.000372	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.07e-05	0.000371	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—BCHE—peripheral nervous system neoplasm	1.07e-05	0.00037	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000355	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—peripheral nervous system neoplasm	1.02e-05	0.000353	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.02e-05	0.000353	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.02e-05	0.000351	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.000348	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—TH—peripheral nervous system neoplasm	1e-05	0.000347	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.97e-06	0.000345	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	9.87e-06	0.000341	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.83e-06	0.00034	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—peripheral nervous system neoplasm	9.76e-06	0.000337	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	9.68e-06	0.000335	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	9.46e-06	0.000327	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	9.34e-06	0.000323	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	9.28e-06	0.000321	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	9.27e-06	0.00032	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.15e-06	0.000317	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	9.09e-06	0.000314	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	8.97e-06	0.00031	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	8.95e-06	0.00031	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.83e-06	0.000305	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.67e-06	0.0003	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	8.62e-06	0.000298	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—peripheral nervous system neoplasm	8.61e-06	0.000298	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	8.6e-06	0.000297	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.55e-06	0.000296	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	8.54e-06	0.000295	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	8.44e-06	0.000292	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	8.28e-06	0.000286	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	8.22e-06	0.000284	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNAS—peripheral nervous system neoplasm	8.2e-06	0.000284	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ABCB1—peripheral nervous system neoplasm	8.05e-06	0.000278	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—peripheral nervous system neoplasm	7.99e-06	0.000276	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	7.85e-06	0.000271	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	7.8e-06	0.00027	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.68e-06	0.000266	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.68e-06	0.000265	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.54e-06	0.000261	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	7.42e-06	0.000256	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.34e-06	0.000254	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.11e-06	0.000246	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—peripheral nervous system neoplasm	7.05e-06	0.000244	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	6.98e-06	0.000241	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.97e-06	0.000241	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.9e-06	0.000239	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	6.84e-06	0.000237	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	6.75e-06	0.000234	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.62e-06	0.000229	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.62e-06	0.000229	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TH—peripheral nervous system neoplasm	6.53e-06	0.000226	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	6.47e-06	0.000224	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.34e-06	0.000219	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.3e-06	0.000218	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	6.27e-06	0.000217	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	6.2e-06	0.000215	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.2e-06	0.000214	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	6.18e-06	0.000214	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	6.11e-06	0.000211	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.98e-06	0.000207	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	5.93e-06	0.000205	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.92e-06	0.000205	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	5.89e-06	0.000204	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	5.83e-06	0.000202	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	5.78e-06	0.0002	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	5.71e-06	0.000197	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	5.66e-06	0.000196	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—peripheral nervous system neoplasm	5.56e-06	0.000192	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.55e-06	0.000192	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	5.44e-06	0.000188	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.44e-06	0.000188	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	5.44e-06	0.000188	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	5.33e-06	0.000184	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.32e-06	0.000184	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	5.23e-06	0.000181	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	4.81e-06	0.000166	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	4.78e-06	0.000165	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.76e-06	0.000165	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	4.72e-06	0.000163	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.72e-06	0.000163	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.67e-06	0.000162	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	4.59e-06	0.000159	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.56e-06	0.000158	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	4.49e-06	0.000155	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.47e-06	0.000155	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—peripheral nervous system neoplasm	4.4e-06	0.000152	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.38e-06	0.000152	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	4.32e-06	0.000149	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	4.01e-06	0.000139	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.77e-06	0.000131	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.75e-06	0.00013	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	3.67e-06	0.000127	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.6e-06	0.000124	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—peripheral nervous system neoplasm	3.58e-06	0.000124	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	3.53e-06	0.000122	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.46e-06	0.00012	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	3.45e-06	0.000119	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.39e-06	0.000117	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.23e-06	0.000112	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.18e-06	0.00011	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	3.16e-06	0.000109	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	3.05e-06	0.000105	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—peripheral nervous system neoplasm	3.05e-06	0.000105	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	3.04e-06	0.000105	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.02e-06	0.000104	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.98e-06	0.000103	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000103	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	2.66e-06	9.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.6e-06	8.99e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	2.55e-06	8.83e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	2.43e-06	8.4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	2.41e-06	8.32e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.38e-06	8.24e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—peripheral nervous system neoplasm	2.21e-06	7.66e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	1.88e-06	6.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.83e-06	6.33e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—peripheral nervous system neoplasm	1.7e-06	5.9e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	1.44e-06	4.97e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.34e-06	4.63e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.3e-06	4.49e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.28e-06	4.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	1.18e-06	4.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	9.9e-07	3.42e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	9.52e-07	3.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	7.02e-07	2.43e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	6.56e-07	2.27e-05	CbGpPWpGaD
